Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical TXA for Post-Mastectomy Seroma Prevention
NCT03738527Phase 4Unknown
- Sponsor
- Hamilton Health Sciences
- Start
- Oct 2019
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tranexamic acid in Seroma, hematoma, sponsored by Hamilton Health Sciences. Status: unknown.
02
Drugs
tranexamic acid
03
Conditions
Seromahematoma
Beyond the preview
Go deeper on NCT03738527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03738527.